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ABSTRACT 
This study evaluated the effects of Nigerian Bee Propolis extract on Methicillin Resistance Staphylococcus Aureus (MRSA) 
infected skin wounds of albino rats.  Two full thickness circular wounds were created each on the dorsum of eighteen (18) healthy 
adult male albino rats with mean body weight of 126±7.09g. Each wound was contaminated with 108 colony forming unit of 
MRSA. The rats were then randomized into three (3) treatment groups (n=6) with topical application of Propolis extract (PE 
Group), Silver sulphadiazine (SS Group) and untreated Control (UT Group). Gross wound healing indices (exudation, edema, 
hyperemia, wound contraction), histopathologic (granulation, angiogenesis, fibroplasia, epithelialization) and immunologic 
healing indices were evaluated using standard methods. Bacteria clearance was through culture and quantification. The wound 
surface exudation and edge edema and hyperemia were prominent in all the groups from day 0 to 6 but persisted in the untreated 
group till day 12. Wound contraction was gradual in all the groups from day 0-18, it was higher between days 0 and 3 in the PE 
and SS than the UT group (P<0.05). Complete wound closure occurred on SS (day 15), and PE (day 16). The histopathological 
changes observed showed neutrophils regressed on day 6 to 18 in all groups and was faster in PE and SS groups (P<0.05). 
Platelets reduction was ` gradual from days 3 to 18 in all groups and was absent from days 6 to 18 in the PE group. Nigerian Bee 
propolis has a profound bacteria clearance and healing effect on wound infected with methicillin resistant staphylococcus aureus 
(MRSA) comparable to silver sulphadiazine and therefore recommended for infected wound treatment. 
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INTRODUCTION 
  
Wound healing is an essential physiological process that 
consists of cells and their products geared towards restoration 
of tissue integrity and functions (Shaw and Martin, 2009; 
Eyarefe et al., 2017). This process is divided into predictable 
phases that include: inflammation, repair and tissue 
remodelling (maturation) (Ning Xu et al, 2016). Wound 
healing is influenced by various factors including: host (Wall 
et al., 2002), wound characteristics (Rosique et al., 2015), 
closure methods  and applied agents (Oguwike et al., 2013). 
Investigation into agents with perceived healing potentials, 
especially, natural products have been intense in recent times, 
due to increasing challenge of bacteria resistance to 
antimicrobials (Eyarefe et al., 2014). 
 Wounds are susceptible to microbial contamination and 
infection (White et al., 2006). Host tissues show evidence of 
erythema, warmth, exudation, pain, tenderness, or induration 
as clinical evidence of infection and damage to tissues (Moore 
and Cowman, 2007). Wound infection prolongs healing 
process (Talan et al., 2011). Several microbial organisms 
including Staphylococcus aureus, Escherichia coli, klebsiella 
pneumonia, Actinobacter baumannii, Pseudomonas 
aeruginosa etc have been isolated from infected wound. 
Staphylococcus aureus is an important cause of wound 
infection in human beings and animals. Methicillin-
resistant S. aureus (MRSA) is of particular concern due to 
limited treatment options and their zoonotic potentials. It is 
also responsible for the majority of all superficial skin 
infections of surgical patients (Lowy, 2003).  
 With current trends in bacterial resistance to antibiotics, 
consideration is being given to topical antimicrobial therapy 
as adjunct to systemic antibacterial in infected wound 
management (Eyarefe et al., 2018). Topical antimicrobials 
have traditionally been formulated for wound management 
(Patel et al., 2008). Natural products such as Aloe vera 
(Vinson et al, 2005), Bannana leaves (Joshua et al, 2013), 
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(Molan, 2011; Eyarefe & Oguntoye, 2016), and Pineapple 
juice (Howat and lewis, 2002) have been used for wound 
treatment. Their efficacies have been investigated with 
measurable indices of wound healing: gross, histopathologic, 
immunologic and immunohistochemical examinations (Gupta 
and Kumar 2015). 
 Bee propolis or bee glue is a resinous material produced by 
honeybees by mixing plant exudates with wax, pollen, 
salivary secretions and bee enzymes (Simone-Finstrom et al, 
2010). The precise composition of propolis varies with the 
geographical location, botanical origin and bee species (Toreti 
et al., 2013). In Nigeria the predominant trees that bees use to 
make propolis are Mahogany, African Nut and black hyedua 
tree and fruit trees such as mango, cashew and coconut trees 
(Ibrahim, 2013). Common content of propolis includes fatty 
and phenolic acids and esters, substituted phenolic esters, 
flavonoids, terpenes, ɓ-steroids, aromatic aldehydes, alcohols, 
derivatives of sesquiterpenes, naphthalene, stilbenes, aliphatic 
acids, aromatic acids, carbohydrates, amino acids, ketones, 
chalcones, dihydrochalcones, terpenoids, vitamins, and 
inorganic substances (Popova, 2003). There is a dearth of 
literature on the pharmacologic potentials of the Nigeria bee 
propolis. Only a few studies on its antidiabetic and 
antihyperglycemic properties have been conducted (Mikhail, 
2013; Babatunde, 2013). Recently, its wound healing 
potentials have been investigated (Eyarefe et al., 2018). 
However, its antibacterial potentials especially, against 
MRSA infected wounds is yet to be known. The prevalence of 
wound cases and surgical site infections in veterinary clinics 
and hospitals in Nigeria (Eyarefe et al., 2011) and the 
limitations of modern methods of wound management due to 
antimicrobial resistance, biocompatibility issues and cost, 
especially in poor resource settings, has led to an increasing 
interest in the healing potentials of natural products. This 
study therefore investigated the healing potential of the 
Nigeria bee propolis on wounds infected with methicillin- 
resistant Staphylococcus aureus in order to provide 
information on its potentials as a possible non-antibiotic, 
natural antimicrobial agent for management of methicillin 
resistant Staphylococcus aureus (MRSA) infected wounds. 
 
 
MATERIALS AND METHODS 
 
Ethical clearance: Ethical approval was obtained from the 
Animal Care and Use Ethical Committee, University of 
Ibadan. 
 
Experimental Animals: Eighteen (18) adult, male Albino 
rats (Wistar strain) were involved in the study. They were 
housed at the experimental animal unit of the faculty of 
veterinary medicine in well ventilated cages, fed with rat 
concentrate feed and Water ad-libitum, and exposed to 
12hours of light and dark period. They were stabilized for the 
period of two weeks before commencement of the study.  
 
Study design: Two excisional wounds were created on the 
dorsum of each rat under anesthesia and each of the wounds 
were contaminated with Staphylococcus aureus (108 Colony 
forming units (CFU). The rats were randomized into 3 groups 
as follows: Group PE= Propolis Extract; Group SS = Silver 
sulphadiazine; Group UT= Control, with 6 rats in each group. 
 
Propolis extraction: Crude Bee propolis was obtained from 
the Apiary unit, Department of Crop Science and Protection, 
University of Ibadan and stored in a dark polythene container. 
The propolis was extracted by maceration at room 
temperature, with occasional shaking in 100 ml of solvent 
(ethanol 80% v/v). The extracts were obtained after 7 days of 
maceration, and filtered. The residue was disposed while the 
filtrate was concentrated to remove the ethanol. After the 
ethanol has been completely evaporated, the propolis jelly 
formed was reconstituted into 10% solution with propylene 
glycol and then stored in a dark bottle for use (Idenize et al., 
2004; FAO, 2016). 
 
Preparation of MRSA inoculum: The bacteria were 
obtained from the Department of Microbiology, University 
College Hospital, University of Ibadan. The microorganism 
was subcultured in nutrient agar and transported in tryptic soy 
broth. 
 
Anaesthesia and wound creation: Each rat was 
premedicated with an intramuscular injection of 2% Xylazine 
HCL at a dose of 5mg/kg body weight and 5% Ketamine at a 
dose of 35mg/kg via the quadriceps group of muscles (Eyarefe 
and Amid, 2010). Following anesthesia, the dorsum (back) of 
each rat was prepared for aseptic surgery. Two full thickness 
excisional skin wound were created on the dorsum of each rat 
as previously described (Eyarefe et al, 2018). Each wound 
area was measured on a graph sheet, contaminated with 108 
colony forming unit (CFU) of Meticillin-resistant 
staphylococcus aureus (MRSA), and rats were returned to 
their cages following recovery from anesthesia for further 
monitoring of wounds. 
 
Confirmation of infection: After 48 hours following wound 
contamination, the presence of infection was confirmed by 
wound hyperemia, edge edema and exudation. Swab samples 
of wound exudate were also obtained for culture as previously 
described (Khoo et al., 2010), in MacConkey and Chocolate 
agar and the bacterial colonies were morphologically 
identified and further confirmed using Gram staining, catalase 
and coagulase tests (Shaikh, 1994). 
 
Wounds treatment: Wound treatment commenced 72hours 
after inoculation. Rats were randomised into treatment groups: 
Propolis Extract (PE), Silver sulphadiazine (SS), 
Control/Untreated (UT). Propolis extract (0.1ml) was applied 
to wounds in PE group, Silver sulphadiazine cream was 
applied copiously on the entire wound surface in SS group, 
while wounds in control group were left untreated. Treatment 
was done once daily for 18 days and the rate of healing was 
monitored daily.  
 
Monitoring with gross wound healing indices: Each animal 
was evaluated for gross wound healing indices (wound surface 
exudation, edge edema, surface hyperemia and rate of wound 
contraction for two weeks as previously described by Eyarefe 
et al, (2014). Wound size (surface area of the wound in (cm3) 
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was measured every three days using a transparent graph 
sheet. The evaluated wound size was employed to calculate 
the percentage of wound contraction, taking initial size of 
wound as 100% by using the following formula: 
 
% Wound contraction = initial wound size – specific day 
wound size/initial wound size × 100. 
A pictorial capture of each wound was also made on each day 
of observation.  
Evaluation of wound bacterial clearance: Swab samples 
were collected from the wound exudates at days 3, 5 and 7 for 
bacterial culture and quantification of colony as earlier 
described (Talan et al., 2011). 
Histopathological evaluation of wound tissues: Following 
euthanasia of 3 animals (one animal per group) at day 3, 6, 9, 
12, 15, 18 with Ketamine (70 mg/kg) and Xylazine (15 
mg/kg), indepth excision of entire wound region with liberal 
margins of the surrounding skin, including the underlying 
connective tissues and fascia above the dorsal muscles were 
excised and fixed in 10% formalin and cut in 5-µm thick serial 
sections, and processed for histopathological examinations. 
Sections were qualitatively assessed under the light 
microscope and the histologic parameters (Leukocyte count, 
fibroblast count, granulation tissue, vascularization, 
fibroelastic tissue and epithelialization) were studied. The 
leucocyte and fibroblast count were expressed as mean and 
standard deviation while the histomorphologic parameters 
(granulation tissue, vascularization, fibroelastic tissue and 
epithelialization) were assessed and scored as described by 
Akriti and Pramod, (2015) with the semi-quantitative four-
point scale scoring system.  
Immunohistochemistry of the wound samples: The staining 
was performed using the avidin-biotin peroxidase complex kit 
(M IHC Select Detection System, HRP/DAB, Merck, 
Germany LOT: 2775482) with slight modification of the 
procedure. Briefly, thin sections (4µm) of the skin were cut in 
triplicates, floated and mounted on APES charged glass slides. 
Each tissue section was deparaffinized before placed in citrate 
buffer solution (10 mM citric acid, pH 6.0) for antigen 
retrieval in microwave for 8 minutes. The sections were 
incubated in 70% methanol with 3% H2O2 for 10 min to inhibit 
endogenous peroxidase activity, and they were then washed 
three times in phosphate buffered saline (PBS). The sections 
were then treated with blocking solution for 10 min. After 
draining of blocking serum, each of the sections were 
individually incubated with primary antibodies (monoclonal 
antibody to EGF at a dilution 1:150 in PBS at 4˚ C overnight 
in a humidified chamber. After washing three times with PBS, 
the sections were treated with biotinylated anti-goat 
polyvalent secondary antibody for 10 min. Then the sections 
were washed three times in PBS and treated with the 
peroxidase-conjugated streptavidin for another 10 min. After 
another PBS bath, the sections were incubated with 3, 3- 
diaminobenzidine (DAB). After colour change, the sections 
were washed in tap water and then counterstained with 
Mayer’s haematoxylin. The slides were mounted with cover 
slips and DPX for examination and grading of staining 
intensities. 
The photomicrographs were taken with a computer enabled 
digital camera (Amscope MU900) attached to the microscope 
(Olympus CX21FS1). The images were quantified for staining 
intensity using reciprocal intensity on the open source Fiji 
(ImageJ) software. The optical density of the staining 
intensities was calculated using the formular;  
 





The gross appearances of the wounds were hyperaemia, 
oedematous with sharp outline at day 0 (DO) till day 3 when 
there was deposition of scab on signs of contraction. At day 6 
(D6), the outlines of the wounds showed remarkable shrinkage 
(contraction), exudation with scab. At day 12 (D12), the 
wounds showed remarkable contraction and closure in the PE 
and SS treatments compared with the UT group (Plate 1). 
 
 
Plate 1.  
Gross appearance of the wounds across the three groups from day 0, 
6, & 12. The wounds are hyperaemic, reflective (oedematous) with 
sharp outline at day 0 (DO). At day 6 (D6), the oulines of the wounds 
show remarkable shrinkage (contraction), exudative with scab 
(granulation tissue). At day 12 (DO), the wounds show remarkable 
contraction. 
PE= Propolis extract; SS= Silver Sulphadiazine; UT= Untreated wounds 
 
Wound exudation: Wound exudation was prominent in all 
the groups, but reduced gradually from day 0 to 6. It was lesser  
in the SS (16%) and PE (25%) at day 7 compared to the UT 
(66%) with the trend being SS < PE < UT (p<0.05) (Plate 1). 
Wound edge edema: Wound edge edema was prominent in 
all the groups from days 0 to 3. It was less  in the PE (33%) 
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and SS (33%) at day 4 compared to the UT (75%) group 
(p<0.05). It was absent in the PE and SS groups from day 5, 
but present in the UT groups (75%) up to day 12 (16%) (Figure 
2).  
 
Wound surface hyperaemia: Wound surface hyperemia was 
prominent in PE from days 0 (100%) to 3 (83%), but was mild 
from day 5 (16%) to 6 (8%). Hyperemia was prominent in SS 
from days 0 (100%) to 3 (91%), mild from days 4 (41%) to 6 
(33%). In the UT, hyperemia was prominent from days 0 
(100%) to 3 (66%), but it became less prominent from days 5 
(33%) to 11 (16%) (Figure 3). 
 
Wound contraction: Wound contraction was gradual in all 
the groups from days 0-18. It was higher at day 9 in the PE 
(37.66±12.25) and SS (46.10±11.91) compared with the UT 
(15.73±9.51) group (P=0.000). The trend continued until day 
15 when healing was complete in the SS group (Figure 4). 
 
Bacteria clearance from wound: The rate of bacterial 
(methicillin resistance staph aureus) clearance in the propolis 
extract group (997.50±34.65) and the silver sulphadiazine 
group (911.00±26.87) was significantly higher than that of the 
untreated group (1502.50±10.61) (P< 0.05). Propolis extract 
and Silver suphadiaxine reduced dense growth of methicillin 
resistance staph aureus on the culture plate at day 3.  Untreated 
wounds allowed dense growth of methicillin resistance staph 
aureus on the culture plate.  At Day 6, PE and SS treatment 
allowed only sparse S. aureus colonies on the plates, while 
untreated wound allowed dense growth of methicillin 
resistance S. aureus on the culture plate. At Day 9, PE and SS 
inhibited growth of S. aureus colony, but untreated wounds 
still showed dense growth of MRSA with some contaminants 
on the culture plates (Fig 2). 
 
Table 1:  
Percentage of wound exudation, edema and hyperaemia in the first two weeks of treatment across the three groups 
Days Wound Exudation Wound Edge Edema Wound surface hyperaemia 
 PE SS UT PE SS UT PE SS UT 
0 12/100 12/100 12/100 12/100 12/100 12/100 12/100 12/100 12/100 
1 12/100 12/100 12/100 12/100 12/100 12/100 12/100 12/100 12/100  
2 12/100 12/100 12/100 11/91 12/100 12/100 12/100 12/100 12/100 
3 12/100 12/100 12/100 8/66 9/75 9/75 10/83 11/91 8/66 
4 9/75  8/66 10/83 4/33 4/33 9/75 6/50 2/16 6/50 
5 9/75 7/58 10/83 0 0 7/58 2/16 2/16 3/25 
6 7/58 6/50 9/75 0 0 5//41 1/8 1/8 3/23 
7 3/25 2/16 8/66 0 0 5/41 0 0 2/16 
8 0 1/8 6/50 0 0 5/41 0 0 2/16 
9 0 0 5/50 0 0 4/33 0 0 2/16 
10 0 0 5/25 0 0 4/33 0 0 2/16 
11 0 0 4/33 0 0 2/16 0 0 2/16 
12 0 0 4/33 0 0 2/16 0 0 0 
13 0 0  1/8 0 0 0 0 0 0 
14 0 0 1/8 0 0 0 0 0 0  
N = number of wounds that showed exudate 
% = percentage of animals that showed wound wetness (exudation)  





Wound contraction rate in the different treatment groups 
of rats with cutaneous wound. 
Figure 2 
Methicillin resistance staph aureus clearance quantification 




Histologic wound healing indices across the three groups from day 0, 
6, & 12. PE showing Inflammatory stage with diffuse cellular 
infiltrates (black arrow) and healing response (white arrow). SS 
showing Inflammatory stage with diffuse acute cellular inflammation 
(black arrow) and healing response (white arrow). UT showing early 
inflammatory stage with marked wound hyperaemia (blue arrow) and 
acute inflammatory cells (black arrow). 
PE= Propolis extract; SS= Silver Sulphadiazine; UT= Untreated 
 
Inflammatory cells response: The number of neutrophils in 
tissues reduced from days 6 to 18 in all groups but it was 
remarkable in the PE and SS treated wounds compared to the 
UT wounds on days 9 and 12 (p<0.05).  Platelets reduced 
gradually from days 3 to 18 in all the wounds but was absent 
from days 6 to 18 in the PE treated wounds.  PE treatment 
showed numerous acute inflammatory cells and granulation 
tissue and remarkable hyperaemia deposition at day 3, and 
fibroblasts at day 9 (Table 2). The epidermis also showed 
hydropic degeneration of keratinocytes at day 6, but there was 
complete healing at day 15. SS treatment showed numerous 
acute inflammatory cells and granulation tissue on the wound 
at day 3, fibroblasts at day 6, wound maturation with well- 
formed collagen (connective tissue) from day 9 to 12. UT 
wounds showed numerous acute inflammatory cells and 
granulation tissue on the wound at day 3 to 9, before 
appearance of fibroblasts, collagen at day 12 through to day 
18 (Figure 4). 
 The wound granulation tissue comprised of budding 
capillaries and type III collagen fibers at day 12 in the SS and 
PE compared to the UT treatment (Table 3). Capillary 
budding/angiogenic blood vessels were high (P<0.05) in the 
UT group on day 9 and 12 when compared to the PE and SS 
groups. The SS groups showed a faster rate of epithelialization 
followed by PE and least in UT treatment (P<0.05). The 
amount of fibro elastic tissue at day 9 was higher in the PE 
than in SS and UT treatments (P<0.05). 
Table 2:  
Inflammatory cells and Fibroblast response on days 3, 6, and 
9 across the three groups 
Histologic 
parameters  
PE SS UT 
 
DAY 3 
   
Macrophages 6.50±0.70a 5.50±3.53 a 2.50±0.70 a 
Monocytes 31.00±16.97 30.00±15.55 36.50±9.19 
Fibroblasts 7.00±4.24 a 5.00±4.24 a 7.50±0.70 a 
Neutrophils 132.00±8.48 a 130.50±14.84 a 126.00±22.62 a 
Mast Cell 3.00±1.41 a 2.50±0.70 a 0.00±0.00 a 
Eosinophils 5.50±4.94 b 1.00±1.41 a 0.00±0.00 a 
Platelets 11.00±1.41 a 12.00±2.82 b 4.50±0.70 a 
 
DAY 6 
   
Macrophages 22.50±14.84a 17.00±7.07 a 23.50±3.53 a 
Monocytes 72.50±14.84 a 80.00±1.41a 78.00±14.14 a 
Fibroblasts 31.00±14.14 a 42.50±9.19 a 58.00±48.08 a 
Neutrophils 59.50±48.79 b 30.50±31.81 a  38.00±48.08 b 
Mast Cell 0.00±0.00 a 0.50±0.70 a 1.00±1.41 a 
Eosinophils 0.00±0.00 a 0.00±0.00 a 0.00±0.00 a  
Platelets 0.00±0.00 1.50±2.12 1.50±2.12 
 
DAY 9 
   
Macrophages 11.00±4.24 b 7.00±1.41 a 6.50±2.12 a 
Monocytes 65.00±4.24 b 21.50±12.02 a 13.00±7.07 a 
Fibroblasts 70.00±2.82 b 25.00±29.69 a 13.00±4.24 a 
Neutrophils 26.00±2.82 a 34.00±39.59 a 84.00±36.76 b 
Mast Cell 1.50±0.70 a 1.00±1.41 a  2.00±0.00 b 
Eosinophils 0.00±0.00 a 1.00±1.41 a 2.50±3.53 a 
Platelets 0.00±0.00 3.00±4.24 b 1.50±2.12 
 
DAY 12 
    
Macrophages 12.00±0.00 b 8.50±2.12 a 7.50±2.12a 
Monocytes 25.00±4.24 a 16.50±2.12 a 44.00±2.82 b 
Fibroblasts 90.00±59.39 b 95.50±38.89 b 9.50±9.19 a 
Neutrophils 5.00±4.24 a 2.50±0.70 a 25.50±4.94 b 
Mast Cell 0.00±0.00 a 0.00±0.00 a 1.50±0.70 b 
Eosinophils 0.00±0.00 a 0.00±0.00 a 0.00±0.00 a 
Platelets 0.00±0.00 a 0.00±0.00 a 10.00±2.82 b 
 
DAY 15 
    
Macrophages 6.50±2.12 a 8.00±0.00 a 5.00±1.41 a 
Monocytes 16.0±1.41 a 21.00±7.10 a 18.00±2.82 a 
Fibroblasts 52.5±10.61 a 139.00±9.90 b 34.00±2.82 a 
Neutrophils 4.0±2.83 b 2.00±2.82 a 3.00±1.41 a 
Mast Cell 0.00±0.00 a 0.00±0.00 a 0.00±0.00 a 
Eosinophils 0.00±0.00 a 0.50±0.70 a 0.00±0.00 a 
Platelets 0.00±0.00 a 0.00±0.00 a 0.00±0.00 a 
 
DAY 18 
    
Macrophages 6.00±2.82 a 6.00±0.00 a 7.00±1.41a 
Monocytes 19.00±4.24 a 14.00±1.41a 15.00±21.21a 
Fibroblasts 67.00±43.84 b 40.00±2.82 a 100.00±56.00 b 
Neutrophils 3.00±1.41 a 5.50±3.53 a 2.00±2.82 a 
Mast Cell 0.00±0.00 a 1.00±1.41 a 0.00±0.00 a 
Eosinophils 0.00±0.00 a 0.00±0.00 a 0.50±0.70 a 
Platelets 0.00±0.00 a 0.00±0.00 a 0.00±0.00 a 
There is significant difference in values with superscript ‘b’ across 
the groups and no significantly difference with values with 
superscript ‘a’ 
PE= Propolis extract; SS= Silver Sulphadiazine; UT= Untreated 
group 
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Table 3:  
Histologic Wound Healing Indices on days 3, 6, 9, 12, 15 
and 18 across the groups 
Histologic parameters PE SS UT 
DAY 3    
Granulation tissue 1.50±0.71b 1.00±0.00b 2.00±0.00b 
Vascularization 2.50±0.71 b 2.00±0.00 a 2.00±0.00 a 
Fibro-elastic tissue 0.00±0.00 a 0.00±0.00 a 0.00±0.00 a 
Epithelialization 1.00±1.41 a 0.00±0.00 b 1.00±0.00 a 
DAY 6    
Granulation tissue 2.00±0.00 a 2.00±0.00 a 2.00±0.00 a 
Vascularization 1.50±0.71 a 2.00±0.00 b 1.50±0.71 a 
Fibro-elastic tissue 2.00±0.00 b 1.50±0.71 a 1.00±0.00 a 
Epithelialization 1.50±0.71 a 1.00±1.41 b 2.00±0.00 b 
DAY 9    
Granulation tissue 1.50±0.71 a 1.50±0.71 b 1.00±0.00 a  
Vascularization 1.00±0.00 a 1.00±1.41 a 2.50±0.70 b 
Fibro-elastic tissue 3.00±0.00 b 2.00±1.41 a 1.50±0.71 b 
Epithelialization 1.00±0.71 a 1.00±1.41 a 0.50±0.71 a 
DAY 12    
Granulation tissue 1.00±0.00 a 2.50±0.71 a 1.00±0.00 a 
Vascularization 0.50±0.71 a 0.00±0.00 a 2.00±0.00 b 
Fibro-elastic tissue 3.00±0.00 a 2.50±1.70 a 2.50±0.71 a 
Epithelialization 1.50±0.71 b 2.00±0.00 b 0.50±0.71 a 
DAY 15    
Granulation tissue 3.00±0.00 a 3.00±0.00 a 3.00±0.00 a 
Vascularization 2.50±0.71 b 0.00±0.00 a 0.00±0.00 a 
Fibro-elastic tissue 2.50±0.71 a 2.50±1.70 a 2.00±0.00 a 
Epithelialization 1.00±1.41 b 2.00±0.00 b 1.50±0.71 b 
DAY 18    
Granulation tissue 1.00±0.00a 2.00±0.00 b 2.50±0.71b 
Vascularization 0.50±0.71a 1.50±2.12 a 1.00±1.41a 
Fibro-elastic tissue 2.50±0.71 a 2.50±1.70 a 2.00±1.41 a 
Epithelialization 1.50±0.71 a 1.51±0.71 a 1.50±0.71 a 
There is significant difference in values with superscript ‘b’ across 
the groups and no significantly difference with values with 
superscript ‘a’ 
PE= Propolis extract; SS= Silver Sulphadiazine; UT= Untreated group 
 
Expression of epidermal growth factor: 
Immunohistochemical evaluation of the intensity of epidermal 
growth factor (EGF) was high in the SS and PE treatments 





This study has futher confirmed the antibacterial properties 
and accelerated the healing potentials of Nigerian Bee propolis 
on cutaneous wound  in rats. The use of Silver sulphadiazine 
as positive control was because of its established bactericidal 
effect against MRSA (Miller et al., 2012).  
The indices evaluated were conventional for assessment of 
topical agent efficacy as previously established in previous 
studies which includes, gross (wound exudation, wound edge 
edema and wound hyperemia), immunologic, and 
histopathologic (granulation tissue, angiogenesis, fibro-elastic 
tissue and epithelialization) evaluation (Eyarefe et al, 2014 ; 




Plate 3  
Immunohistochemical expression of EGF (arrows) on the 
healing wounds across the three groups from day 3, 9& 18 
PE= Propolis extract;  
SS= Silver Sulphadiazine;  
UT= Untreated treatment 
 
The prominence of wound surface exudation, edema and 
hyperemia in all the groups for the first six days was due to 
the enhanced acute local inflammatory response, but gradually 
phased out in the SS and PE treatments. The early complete 
wound closure in the PE as well as SS treatments was related 
to the contraction of the wound and possibly enhanced 
fibroblastic response and re-epithelization. These indices are 
indications of tissue response to injury (Rosique et al, 2015).  
The rate of bacterial clearance in the PE treatment was also 
directly proportional to healing of the wound. This may not be 
unrelated to the presence of flavonoids in propolis. Its anti-
edema and anti-hyperaemic effects can be ascribed to the anti-
inflammatory and antimicrobial properties of flavonoids such 
as quercetin, naringenin and Caffeic acid phenethyl ester 
(CAPE). They reduce the production and release of histamine 
and other inflammatory mediators such as interleukins and 
tumor necrosis factor-α (de Moura, 2011). Terpenoids are 
phytochemicals that have been shown to possess antibacterial 
and antifungal properties (Mirzoeva et al, 1996). 
Anthraquinones and Cardiac glycosides which are present in 
this propolis sample have been used to treat inflammation and 
edema (Khan et al, 2011). The in vitro antibacterial activity of 
propolis has been verified against both Gram-positive and 
Gram-negative bacteria and this is as a result of synergism 
between propolis compounds, mainly pinocembrin and 
galangin flavonoids (Cushnie et al, 2005).  
 Local signs of acute inflammation to injury in clean 
wounds are wound edge edema and hyperemia and could be 
signs of wound infection and evidence of debridement 
challenges when these signs progress beyond day 3 of injury 
(Eyarefe et al, 2014, Patrick, 2016). This observation may 
provide a rationale for the prolonged wound exudations and 
hyperemia observed between days 5 to 12 in the untreated 
group. The reduction in edema and surface hyperemia seen in 
wounds treated with Silver sulphadiazine is in line with the 
use of silver sulphadiazine as a drug of choice in treating burn 
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wounds due to its wide spectrum of bactericidal activity 
against both gram-positive and gram-negative organisms 
(Miller et al, 2012). More so, the wound contraction rate could 
be traced to the ability of propolis to influence the production 
of Transforming growth factor- alpha and beta 1 (TGF-α & 
TGF-β1) by immune cells which stimulates cell growth, 
mobilization of fibroblasts and epithelial migration (Simona 
et al, 2015). Some of the fibroblast transform to 
myofibroblasts, which is mainly responsible for wound 
contraction (Patrick, 2016).  Wound contraction was slower in 
the untreated group due to inadequate production of 
granulation tissues as a result of extended inflammatory and 
debridement phases (Rosique et al, 2015).  
 Our findings showed that Nigerian Bee propolis extract 
increased the rate of wound healing and re-epithelialization of 
full thickness skin wounds infected with methicillin resistance 
staphylococcus aureus in rats due to its immunomodulatory, 
anti-inflammatory, antioxidant and inhibition of bacterial 
growth and tissue regenerative properties. Propolis is known 
to possess a number of pharmacological properties such as: 
anti-inflammatory, anti- acceleration of regenerating 
processes of damaged cartilages and bones (Park et al, 2002), 
immunomodulatory (Qiao, 1991), antimicrobial (Silva et al., 
2008) antioxidant (Cushnie and Lamb, 2005), as analgesic 
(Demestre, 2008), as an anti-inflammatory agent (Fearnely, 
2001) and antitumoral agent (Gavanji, 2015) properties.  
In conclusion, Nigerian Bee propolis has a profound healing 
effect on wound infected with meticillin resistant 
staphylococcus aureus (MRSA) comparable to silver 
sulphadiazine and therefore, it is recommended for treatment 
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